SCNI NASDAQ
Scinai Immunotherapeutics Ltd.
1W: -14.2%
1M: -43.2%
3M: +394.8%
YTD: +82.3%
1Y: -4.3%
3Y: -84.9%
5Y: -99.4%
$1.33
+0.02 (+1.53%)
Weekly Expected Move ±34.0%
$0
$1
$1
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Balance Sheet Trends
Total Assets
$13M
-23.0% ▼
5Y CAGR: -16.7%
Total Liabilities
$3M
-84.3% ▼
5Y CAGR: -41.9%
Shareholders Equity
$10M
+318.4% ▲
Cash & Investments
$2M
-59.7% ▼
5Y CAGR: -37.7%
Total Debt
$2M
-89.9% ▼
5Y CAGR: -44.0%
Net Debt
$122K
-99.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $3M | $17M | $14M | $5M | $2M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $3M | $17M | $14M | $5M | $2M |
| Net Receivables | $71K | $325K | $0 | $330K | $217K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $33 | -$84K | $250K | $176K | $131K |
| Total Current Assets | $3M | $18M | $14M | $5M | $2M |
| Property, Plant & Equip. | $14M | $14M | $13M | $12M | $11M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $147K | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | -$150 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $14M | $14M | $13M | $12M | $11M |
| Total Assets | $18M | $32M | $27M | $17M | $13M |
| — Liabilities — | |||||
| Accounts Payable | $581K | $999K | $716K | $535K | $376K |
| Short-Term Debt | $19M | $248K | $0 | $396K | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $225K |
| Other Current Liabilities | $0 | -$248K | $0 | -$396K | $0 |
| Total Current Liabilities | $20M | $2M | $2M | $2M | $2M |
| Long-Term Debt | $0 | $27M | $20M | $19M | $260K |
| Other Non-Current Liab. | $383K | $31K | $5M | $96K | $3K |
| Total Non-Current Liabilities | $2M | $29M | $26M | $20M | $2M |
| Total Liabilities | $22M | $31M | $29M | $22M | $3M |
| — Equity — | |||||
| Common Stock | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$101M | -$110M | -$116M | -$122M | -$118M |
| Accumulated OCI | $0 | -$2M | -$2M | -$2M | -$2M |
| Total Stockholders Equity | -$5M | $982K | -$2M | -$5M | $10M |
| Total Liabilities & Equity | $18M | $32M | $27M | $17M | $13M |
| — Key Metrics — | |||||
| Total Debt | $21M | $29M | $22M | $21M | $2M |
| Net Debt | $18M | $12M | $7M | $16M | $122K |
| Total Investments | $147K | $0 | $0 | $0 | $0 |